Inventor · disambiguated record
David Alan Heldreth, Jr.
Also filed as: HELDRETH JR DAVID ALAN
2 granted patents·12 pending applications·2 citations·filing 2018–2024
38Inventor score
Files withHELDRETH JR DAVID ALAN14
Top patents by PatentIndex Score
14 records- 0173US10874102B2Use of ABA/methyl jasmonate/sugar to increase terpene and cannabinoid production in Cannabis SativaHELDRETH JR DAVID ALAN·Filed 2018·Granted Dec 29, 2020·2 cites·10 claims
- 0273US2024398751A1Methods of treating or reducing symptoms of stimulant dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and glutamate allosteric modulatorsHELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0373US2024325343A1Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators where the method of delivery/formulation selected from: Inhaler, nebulizer, intravenously, intramuscularly, injection, capsules, tablets, pills.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0473US2024269107A1Methods of treating or reducing symptoms of brain cancer such as glioma and glioblastoma via combination therapy with allosteric modulators and phenethylamines.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0573US2024398750A1Methods of treating or reducing symptoms of anxiety, depression, attention deficiency (ADD), attention deficient hyperactivity (ADHD), obsessive compulsive (OCD), Bipolar disorder, and related disorders/conditions via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and other allosteric modulators.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0673US2024325344A1Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0773US2024325342A1Methods of treating or reducing symptoms of opiate dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and opiate allosteric modulatorsHELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0873US2024299341A1Methods of treating or reducing symptoms of nicotine dependency (addiction) such as tobacco-use (smoking, vaping, sublingual, oral) and/or tobacco smoking cessation via combination therapy with allosteric modulators and phenethylamines.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 0973US2024325345A1Methods of increasing effects of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, opiate allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 1073US2024261252A1Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses.HELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 1165US2022265601A1Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses.HELDRETH JR DAVID ALAN·Filed 2022·Application pending·0 cites
- 1260US2025000037A1Production and use of the leaf and/or leaves and/or stem(s) and/or stalk(s) of plants of the cannabis species for consumption as a food, beverage ingredient, supplement, medicineHELDRETH JR DAVID ALAN·Filed 2024·Application pending·0 cites
- 1356US12274210B2Production and use of the leaf and/or leaves and/or stem(s) and/or stalk(s) of plants of the cannabis species for consumption as a food, beverage ingredient, supplement, medicineHELDRETH JR DAVID ALAN·Filed 2022·Granted Apr 15, 2025·0 cites·4 claims
- 1453US2022248709A1Creation of novel protein products from hemp and hemp derivativesHELDRETH JR DAVID ALAN·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Alan Heldreth, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →